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Abstract: Millions of people are exposed to arsenic in drinking water, which at high 
concentrations is known to cause lung cancer in humans. At lower concentrations, the risks 
are unknown. We enrolled 196 lung cancer cases and 359 controls matched on age and 
gender from western Nevada and Kings County, California in 2002–2005. After adjusting 
for age, sex, education, smoking and occupational exposures, odds ratios for arsenic 
concentrations ≥85 µg/L (median = 110 µg/L, mean = 173 µg/L, maximum = 1,460 µg/L) 
more than 40 years before enrollment were 1.39 (95% CI = 0.55–3.53) in all subjects and 
1.61 (95% CI = 0.59–4.38) in smokers. Although odds ratios were greater than 1.0, these 
increases may have been due to chance given the small number of subjects exposed more 
than 40 years before enrollment. This study, designed before research in Chile suggested 
arsenic-related cancer latencies of 40 years or more, illustrates the enormous sample sizes 
needed to identify arsenic-related health effects in low-exposure countries with mobile 
populations like the U.S. Nonetheless, our findings suggest that concentrations near  
100 µg/L are not associated with markedly high relative risks. 
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1. Introduction 
Millions of people are exposed to arsenic in drinking water. In Bangladesh alone, >50 million 
people have been exposed to concentrations exceeding the World Health Organization guideline of  
10 µg/L [1]. In 2001, the United States Environmental Protection Agency estimated that about  
13 million people in the U.S. had public water supplies exceeding the new 10 µg/L regulatory  
limit [2]. More recent estimates suggest that over two million people in the U.S. may be exposed to 
concentrations >10 µg/L through private wells [3].  
The International Agency for Research on Cancer has classified arsenic in drinking water as a 
known cause of human cancer of the skin, bladder, and lung [4]. Numerous studies have shown that 
the human lung is especially susceptible to ingested arsenic [5–9], and some data suggest that lung 
cancer is the most common cause of death from arsenic in drinking water [10,11].  
The cancer risks associated with arsenic in drinking water, even at relatively low concentrations, 
may be quite high. An expert committee of the U.S. National Research Council estimated that lifetime 
exposure to arsenic at 10 µg/L may be associated with an excess risk of lung or bladder cancer as high 
as one case for every 300 people exposed [6]. These risks may be even higher in populations with 
early-life exposures [12], certain diets, genetic characteristics [13], or exposure to other carcinogens 
like tobacco smoke [14–16]. Importantly, these estimated risks, and the 10 µg/L arsenic standard,  
are based on linear extrapolations of cancer risks observed with concentrations above 200 µg/L. The risks 
from lower arsenic concentrations are unknown. This is important because most concentrations 
worldwide are <100 µg/L, and it is unknown if the arsenic-cancer dose-response relationship at lower 
levels is truly linear. Some authors have suggested that this might not be the case, and the current 
standard of 10 µg/L may be either overly or insufficiently protective [17,18]. This controversy, fueled 
by the high costs of removing arsenic from contaminated water, highlights the importance of clarifying 
health risks near or below 100 µg/L.  
The purpose of the present study was to investigate arsenic-associated lung cancer risks using a 
case-control study design in a population exposed to low to moderate arsenic levels in drinking water. 
This is the first lung cancer study on the largest U.S. populations with arsenic exposures between  
50 and 100 µg/L [19], and the first study of lung cancer incidence in the entire U.S. with individual 
data on past drinking water arsenic concentrations [4–8]. 
2. Methods 
2.1. Study Area 
The study area consisted of six counties in western Nevada (Carson, Churchill, Douglas, Lyon, 
Mineral, and Storey) and Kings County in central California. In Churchill County, in the city of Fallon 
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(population 8,600 in 2010), arsenic concentrations in public drinking water supplies were  
85–125 µg/L from 1942 until 2004, when a treatment plant reduced concentrations to <10 µg/L [16,20]. 
In Hanford, California (population 54,000 in 2010), measurements averaged 110 µg/L in 1967,  
90 µg/L in 1974, 68 µg/L in 1982, <40 µg/L in 2004, and <10 µg/L since 2009 [21,22]. A few other 
small towns in these counties had arsenic concentrations between 10 and 50 µg/L, and some private 
wells still exceed 100 µg/L, especially around Fallon. Most other water supplies in the study area had 
arsenic concentrations below 10 µg/L, offering a marked contrast in exposure [16].  
2.2. Participant Selection 
Inclusion criteria for lung cancer cases were: (1) Primary lung cancer first diagnosed between 2002 
and 2005, (2) Histologic confirmation, (3) Over 25 years old when diagnosed, (4) Living in the study 
area at the time of diagnosis, and (5) Able to provide interview data (or having a next of kin or other 
close relative who could). In Nevada, lung cancer cases were ascertained using rapid case 
ascertainment, in which subjects were identified directly from each hospital in the study area as well as 
from hospitals in Reno, Nevada, the large metropolitan center neighboring the study area.  
In California, lists of subjects meeting inclusion criteria were provided by the Cancer Registry of 
Central California, which abstracted cases from all hospitals in Kings County and neighboring 
counties. Completeness of the Cancer Registry of Central California has been estimated at 95% [16]. 
Completeness of Nevada case ascertainment is estimated at 84% based on lung cancer incidence rates 
from the Nevada State Health Division for the years of this study [23]. 
Controls were selected using random digit dialing of home telephone numbers in the study area and 
frequency-matched to cases by 5-year age group, gender, and state (California or Nevada). At the time 
of control ascertainment, few people in the study area had cellular phones and >90% had home phones. 
Inclusion criteria for controls were: (1) Never diagnosed with lung or bladder cancer; (2) Over  
25 years old; (3) Living in the study area at the time of first contact; and (4) Able to provide interview 
data (or having a close relative who could). All procedures were approved by the University of 
California, Berkeley institutional review board. All participants gave informed written consent.  
2.3. Interviews 
Participants were interviewed over the telephone by a trained interviewer using a standardized study 
questionnaire. The closest relative (e.g., spouse or child) was interviewed for 93 of the 196 cases 
(47%), who were too ill to respond or deceased. Participants were asked to provide the locations of all 
residences occupied for six months or longer over their lifetimes, including street addresses when 
possible. For each residence, participants were asked about drinking water sources (private well, 
community supply, bottled water, or other) and filter use at the time they lived there. 
Participants were also asked how many glasses of water and water-based beverages and foods (e.g., 
coffee, condensed soup) they typically consumed one year prior to the interview or diagnosis, as well 
as 20 and 40 years before. They were reminded of where they lived, what work they did, and other 
major events in their lives to help them recall past drinking water intake. Respondents were asked to 
estimate consumption of tap water and other fluids separately for home, work, and other places. 
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Questions regarding tobacco covered ages when smoking started and stopped, typical number of 
packs smoked per week, and exposure to secondhand smoke as a child and adult. Finally, participants 
were asked to describe all jobs held for six months or longer and their knowledge of contact with  
17 specific chemical, occupational and environmental exposures associated with lung cancer, 
including asbestos, silica, fiberglass, and fumes [24]. Jobs were classified as low, possible, or high risk 
by researchers blinded to disease and exposure status of subjects, based on the extent of participant 
exposures and the degree of evidence linking specific exposures to elevated lung cancer risks. 
2.4. Arsenic Exposure Assessment 
All known previous residences in the study area were linked to drinking water arsenic concentrations 
by researchers blinded to case-control status. Arsenic measurements for all community-supplied 
drinking water and for thousands of private domestic wells within the study area were provided by the 
Nevada State Health Division and the California Department of Health Services. In all, we obtained 
over 7,000 arsenic measurements. For all large community water sources, records dated back 25 years 
or more. When historical records were unavailable, efforts were made to collect a water sample from 
the residence. Previous research showed that arsenic concentrations in study area wells were relatively 
stable over time, with Spearman correlation coefficients ranging from 0.84 to 0.94 in samples collected 
up to 20 years apart [25]. If a well could not be measured, the median of all wells within the same 
square-mile section (defined by the U.S. Public Land Survey) was used. If <2 wells existed in the 
section, the median of all wells within 3,000 m was used, except around Fallon, where arsenic 
concentrations were more variable. Here, the median of all wells of similar depth (either above or 
below 14 m) within 2,000 m was used. Other estimates for unmeasured wells were evaluated (e.g.,  
the single nearest measured well, the mean or median of all wells within 500 to 5,000 m) but these did 
not improve predictions in analyses involving randomly selected wells with known arsenic 
concentrations. Researchers were blinded to case-control status when calculating these proxy 
estimates. For bottled water and exposures outside the study area, arsenic levels were assigned values 
of zero. Water treated with a filter known to remove arsenic (e.g., reverse osmosis) was assigned 21% 
of the pre-filtered concentration [3]. 
2.5. Statistical Methods 
Odds ratios were calculated using unconditional logistic regression because we used frequency 
matching rather than perfect 1:2 matching of cases and controls [26]. In the final analyses, each 
participant’s highest 1-, 5-, and 20-year average arsenic concentration was categorized as ≤10 (the U.S. 
regulatory standard), 11–84, or ≥85 µg/L (the level historically found in Hanford and Fallon).  
Recent research, mostly developed after this study was initiated, suggests arsenic-cancer latencies  
≥40 years [12,27,28]. Therefore, analyses used various lag periods (e.g., excluding exposures less than 
40 years before diagnosis (for cases) or interview (for controls)). Lifetime cumulative exposure was 
calculated by multiplying each residential arsenic concentration by the number of years at that 
residence, summed over all residences occupied by the participant. These were categorized as ≤0.1, 
0.11–2,399, and ≥2,400 µg/L-years (equivalent to 30 years of exposure to 80 µg/L). 
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Arsenic intake (in µg/year) was estimated for each subject by multiplying residential arsenic 
concentrations by the amount of water reportedly consumed 1, 20, or 40 years ago (whichever was 
closest to the years the subject lived in the residence). Previous research has shown that intake of 
dietary variables including coffee and tea can be accurately recalled from the distant past [29], 
although similar data on water intake are not available. Odds ratios were similar whether or not 
drinking water intake data were used, so our primary analyses involved drinking water concentrations 
rather than intake. 
In the final models, odds ratios were adjusted for sex, age (in 10-year age groups), smoking 
(categorized as never, moderate (<10 packs/week), or heavy (≥10 packs/week on average during 
period of regular smoking)), occupational or other exposure to known lung carcinogens (as dummy 
variables for possible or high risk), and education (dummy variable for beyond high school). Other 
variables, including continuous measures of smoking (e.g., pack-years), former smoking, secondhand 
smoke exposure, body mass index (BMI), income, and state (California or Nevada), had little impact 
on results and were therefore not included in final models. Student’s t-tests were used to compare the 
means of continuous variables. All p-values are two-tailed. All analyses were done in SAS version 9.2 
(SAS Inc., Cary, NC, USA). 
3. Results 
The names of 312 lung cancer cases were received from the cancer registry and hospitals in 
California and Nevada. Of these, 45 could not be located (and thus could not be confirmed to have 
lived in the study area), and 27 were ineligible because they did not live in the study area or could not 
provide an interview or next of kin interview due to illness or language issues. Of the remaining  
240 cases, 44 (18%) declined to participate. Among 476 controls meeting inclusion criteria, eight could 
not be located after initially agreeing to participate, and 29 were ineligible due to illness or language 
issues. Of the remaining 439 controls, 80 (18%) declined to participate. This led to a final sample size 
of 196 cases and 359 controls. 
Table 1 shows demographic characteristics of participants. As expected, lung cancer cases and 
controls were similar in terms of variables used for frequency matching, including state of residence 
(OR = 1.18, 95% CI = 0.78–1.76) and gender (OR = 1.22, 95% CI = 0.86–1.74). The average age of 
cases was 70.2 ± 10.0 (mean ± SD), compared to 69.0 ± 8.6 for controls (p = 0.13). Cases had lower 
incomes and were less educated than controls. They were similar in terms of race. Only 3.6% of cases 
reported never smoking regularly, compared to 40.9% of controls (OR = 18.7, 95% CI = 8.9–44.3). 
Cases were also less likely to report exposure to other lung carcinogens and had lower BMIs, but these 
differences were small. 
Table 2 shows drinking water characteristics of participants. Cases reported higher water intake 
(averaging 2.42 L/day compared to 2.12 L/day for controls) but spent slightly less time in the study 
area (34% of person-years preceding enrollment compared to 40% for controls). While living in the 
study area, cases were more likely to use public supplies (74% of person-years compared to 62% for 
controls). Controls were more likely to use bottled water (10% versus 6% for cases) and private wells 
(29% versus 19% for cases). Most bottled water had low arsenic concentrations (<10 µg/L). Out of 
293 wells reportedly used by participants in the study area, we measured or found records for 75 
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(measured between 1980 and 2010). We used proxy measurements or estimated concentrations for 87, 
which accounted for 6% of total person-years in the study area for cases, and 7% for controls.  
The remaining 131 wells, classified as unknowns, accounted for 8% and 10% of total person-years in 
the study area for cases and controls, respectively. Concentrations in wells ranged from  
non-detectable to 1,460 µg/L (median = 7 µg/L, mean = 36 µg/L). A similar percentage of cases and 
controls had 5-year average arsenic concentrations ≥85 µg/L at least 40 years before enrollment and 
cumulative exposures ≥2,400 µg/L-years. 
Table 1. Demographic characteristics of lung cancer cases and controls, western Nevada 
and central California, 2002–2005. 
 Cases (n = 196) No. % Controls (n = 359) No. % Crude OR 95% CI 
State * 
Nevada 
California 
 
146 
50 
 
74.5 
25.5 
 
278 
81 
 
77.4 
22.6 
 
1.00 
1.18 
 
 
0.78, 1.76 
Gender *        
Females 106 54.1 212 59.1 1.00  
Males 90 45.9 147 40.9 1.22 0.86, 1.74 
Income        
<$20,000 per year 50 25.5 65 18.1 1.00  
$20–80,000 per year 105 53.6 214 59.6 0.64 0.41, 0.99 
>$80,000 per year 14 7.1 55 15.3 0.33 0.17, 0.66 
Don’t know or refused 27 13.8 25 7.0 1.40 0.73, 2.71 
Education       
High school or less 149 76.0 210 58.5 1.00  
More than high school 47 24.0 149 41.5 0.44 0.30, 0.66 
Race        
Caucasian 182 92.9 323 90.0 1.00  
Hispanic 4 2.0 17 4.7 0.42 0.14, 1.26 
Other 10 5.1 16 4.5 1.11 0.49, 2.50 
Unknown 0 0.0 3 0.8 -- -- 
Smoking       
Never smoked  7 3.6 147 40.9 1.00  
<10 packs/week ** 117 59.7 160 44.6 15.4 6.94, 34.0 
≥10 packs/week ** 72 36.7 52 14.5 29.1 12.6, 67.2 
Other lung carcinogen ***       
No 164 83.7 271 75.5 1.00  
Yes 32 16.3 88 24.5 0.60 0.38, 0.94 
 Mean SD Mean SD p-Value  
Age (years) * 70.2 10.0 69.0 8.6 0.13  
Body Mass Index (kg/m2) 24.6 4.3 25.9 4.4 <0.001  
CI confidence interval, OR odds ratio, SD standard deviation. * Participants were frequency matched on age, 
sex, and state; ** Average packs of 20 cigarettes (or equivalent for cigars and pipes) usually smoked per 
week during period of regular smoking, if ever smoked >6 months; *** Possible exposure to known lung 
carcinogens including radon, asbestos, silica, fumes and smoke.  
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Table 2. Drinking water characteristics of lung cancer cases and controls, western Nevada 
and central California, 2002–2005. 
 Cases Controls p-Value 
Average tap-water intake (L/day)    
Current 2.24 2.04 0.20 
20 years ago 2.84 2.35 0.03 
40 years ago 
Total 
2.17 
2.42 
1.96 
2.12 
0.27 
0.05 
Person-years inside study area (%) * 
Lifetime before enrollment  
<40 years before enrollment 
≥40 years before enrollment 
 
33.6 
50.2 
11.2 
 
39.9 
59.0 
13.0 
 
<0.01 
<0.01 
<0.01 
Water source (% of person-years) **    
Public 74.4 61.5 <0.01 
Bottled  5.6 9.6 <0.01 
Private well 19.0 28.5 <0.01 
Available records or measurements 5.1 11.6 <0.01 
Proxy measurement 6.2 7.0   0.06 
No record or measurement 7.7 9.9 <0.01 
Other 0.8 0.3 <0.01 
Unknown 0.4 0.0 ----- 
Water source ≥40 years before enrollment (% of person-years) ** 
Public 77.0 59.5 <0.01 
Bottled  4.9 12.4 <0.01 
Private well 18.1 28.1 <0.01 
Available records or measurements 8.0 15.2 <0.01 
Proxy measurement 2.4 5.9 <0.01 
No record or measurement 7.7 7.0 0.61 
Other 0.1 0.0 ----- 
Unknown 0.4 0.0 ----- 
Arsenic concentration (%) *** 
Highest 5-year average: 10-year lag 
   
≤10 µg/L 71.9 67.1  
11–84 µg/L 18.9 22.8  
≥85 µg/L 
Average concentration (µg/L) 
9.2 
24.7 
10.0 
23.3 
 
0.87 
Highest 5-year average: 40-year lag     
≤10 µg/L 86.2 87.5  
11–84 µg/L 7.7 7.5  
≥85 µg/L 
Average concentration (µg/L) 
6.1 
16.6 
5.0 
9.9 
 
 0.40 
Cumulative exposure: 10-year lag    
≤0.1 µg/L-years 35.7 31.5  
0.11–2,399 µg/L-years 58.2 64.6  
≥2,400 µg/L-years 
Average exposure (µg/L-years) 
6.1 
263.4 
3.9 
142.2 
 
 0.38 
* Person-years inside the study area divided by total person-years lived. ** Person-years for each source 
divided by person-years in the study area. *** Percent of subjects in each category, adjusted for filter and 
bottled water use. 
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A supplemental file shows smoking and drinking water characteristics for each of the 30 subjects with 
arsenic concentrations ≥85 µg/L (median = 110 µg/L, mean = 173 µg/L) at least 40 years before 
enrollment. Twenty-four subjects (80%) were exposed through the public supply of Hanford, California, 
which was estimated to have concentrations of 110 µg/L until 1970. Three (10%) were exposed through 
the public supply of Fallon, Nevada, which was estimated at 90 µg/L. Three more (10%) had 
concentrations >110 µg/L (all private wells near Fallon, Nevada), the highest being 1,460 µg/L.  
Table 3 shows lung cancer odds ratios for various categories of arsenic exposure, with 10- and  
40-year lags, for all subjects. Odds ratios with 5- and 20-year lags (not shown in tables) were lower 
than those with 40-year lags (e.g., 0.68, (95% CI = 0.34–1.37) and 0.76 (95% CI = 0.36–1.60), 
respectively, for highest 5-year average arsenic concentrations ≥85 µg/L). Odds ratios were also near 
1.0 with 10-year lags. For highest 5-year average concentrations ≥85 µg/L lagged 40 years and 
cumulative exposures ≥2,400 µg/L-years, adjusted odds ratios were above 1.0, but 95% confidence 
intervals were wide (OR = 1.39, 95% CI = 0.55–3.53 and OR = 1.20, 95% CI = 0.45–3.22, 
respectively). In analyses confined to smokers (Table 4), corresponding adjusted odds ratios were 
slightly higher (OR = 1.61, 95% CI = 0.59–4.38 and OR = 1.26, 95% CI = 0.45–3.56), but confidence 
intervals still included 1.0. 
Table 3. Odds ratios and 95 percent confidence intervals for arsenic in drinking water and 
lung cancer in western Nevada and central California, 2002–2005. 
 Cases Controls Unadjusted Adjusted * 
 OR 95% CI p OR 95% CI p 
Highest 5-year average: 10-year lag         
≤10 µg/L 141 241 1.00   1.00   
11–84 µg/L 37 82 0.77 0.50–1.20 0.25 0.75 0.45–1.25 0.27 
≥85 µg/L 18 36 0.85 0.47–1.56 0.61 0.84 0.41–1.72 0.63 
Highest 5-year average: 40-year lag         
≤10 µg/L 169 314 1.00   1.00   
11–84 µg/L 15 27 1.03 0.53–1.99 0.92 0.84 0.40–1.79 0.66 
≥85 µg/L 12 18 1.24 0.58–2.63 0.58 1.39 0.55–3.53 0.48 
Cumulative exposure: 10-year lag         
≤0.1 µg/L-years 70 113 1.00   1.00   
0.11–2,399 µg/L-years 114 232 0.79 0.55–1.15 0.22 0.75 0.48–1.15 0.18 
≥2,400 µg/L-years 12 14 1.38 0.61–3.16 0.44 1.20 0.45–3.22 0.71 
CI confidence interval, OR odds ratio. * Adjusted for age, sex, education, smoking history (never, moderate  
(<10 packs/week), or heavy (≥10 packs/week)), and possible exposure to another known lung carcinogen.  
Odds ratios were similar when highest 1-year averages were used instead of highest 5-year 
averages, when next of kin data were excluded, and when proxy measurements for wells were replaced 
with zeroes, the concentration in the closest measured well, or the median or mean arsenic 
concentrations of all wells within various distances of the unmeasured well, as described in Section 2.4. 
A clear relationship between arsenic and lung cancer risk was still not apparent when lower exposure 
categories (e.g., <0.1, 0.1–10, and >10 µg/L) were evaluated. When arsenic exposure was entered as a 
continuous variable (either as the highest five-year average concentration or as cumulative exposure), 
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odds ratios (e.g., for each 1 µg/L increase in arsenic concentration), were all near 1.00 and not 
statistically significant, even with 40-year lags (data not shown). Odds ratios for exposures less than  
40 years before enrollment were also near 1.00 and not statistically significant, for either smokers or 
all subjects. 
Table 4. Odds ratios and 95% CIs for arsenic in drinking water and lung cancer among 
ever smokers in western Nevada and central California, 2002–2005. 
 
Cases Controls 
Unadjusted Adjusted * 
 OR 95% CI p OR 95% CI p 
Highest 5-year average: 10-year lag         
≤10 µg/L 136 148 1.00   1.00   
11–84 µg/L 35 47 0.81 0.49–1.33 0.41 0.73 0.43–1.23 0.24 
≥85 µg/L 18 17 1.15 0.57–2.33 0.69 0.90 0.42–1.92 0.79 
Highest 5-year average: 40-year lag          
≤10 µg/L 164 187 1.00   1.00   
11–84 µg/L 13 18 0.82 0.39–1.73 0.61 0.66 0.30–1.44 0.30 
≥85 µg/L 12 7 1.95 0.75–5.08 0.17 1.61 0.59–4.38 0.35 
Cumulative exposure: 10-year lag         
≤0.1 µg/L-years 69 72 1.00   1.00   
0.11–2,399 µg/L-years 108 133 0.85 0.56–1.29 0.44 0.68 0.43–1.06 0.09 
≥2,400 µg/L-years 12 7 1.79 0.67–4.81 0.25 1.26 0.45–3.56 0.66 
CI confidence interval, OR odds ratio. * Adjusted for age, sex, education, smoking history (moderate (<10 packs/week) 
or heavy (≥10 packs/week)), and possible exposure to another known lung carcinogen.  
4. Discussion 
Overall, this study did not identify clear or markedly increased risks of lung cancer in people 
exposed to arsenic in drinking water at concentrations near 100 µg/L. The finding of higher odds ratios 
with longer lag periods is consistent with recent research suggesting an extended latency period for 
arsenic-related cancers [12,27,28]. In analyses focused on exposures 40 years ago or more, odds ratios 
for average exposures ≥85 µg/L were 1.39 (95% CI = 0.55–3.53) in all subjects and 1.61  
(95% CI = 0.59–4.38) in smokers. Although odds ratios were greater than 1.0, these increases may 
have been due to chance given the small number of subjects exposed more than 40 years before 
enrollment. 
There are several possible reasons why statistically significant increased risks were not identified in 
this study. It may be that concentrations near 100 µg/L are not associated with increased lung cancer 
risks in this population, or they are associated with increased risks too low to be detected at a 
statistically significant level in a study the size of ours. When this study was conducted, it was not 
evident that the latency between arsenic exposure and lung cancer might be much longer than that of 
tobacco, which is about 20 years [30]. In northern Chile, lung cancer rate ratios did not peak until at 
least 30 years after high exposures began [27] and remain very high (OR = 4.4, 95% CI = 2.6–7.4) 
nearly 40 years after high exposures ended [28]. Other studies have also found latency periods of  
20 years or more [12,16,31,32]. 
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Although arsenic-exposed areas comprised about 28% of the study population during subject 
ascertainment [33], only 9% of controls lived in these areas ≥40 years before interview. This high 
migration rate was also seen in the 2000 U.S. Census, where 35% of people in Fallon reported living 
outside the county just five years earlier. Overall, the small percentage of people who lived in the more 
exposed parts of our study area during the most relevant risk period (≥40 years before cancer 
diagnosis) contributed to the low power of this study, and can be a major limitation of other arsenic 
studies investigating associations with long latency periods. 
Despite low power, the findings of our study are important for several reasons. First, they provide 
an example of the difficulties and tremendously (if not prohibitively) large sample sizes needed to 
identify arsenic-related health effects in low-exposure countries with mobile populations like the U.S. 
This highlights the importance that highly exposed countries like Taiwan, Bangladesh, India, and Chile 
have played in generating new information on arsenic [4–15,27,28]. Secondly, while this study was not 
large enough to help confirm or rule out increased risks of 40–60%, the confidence intervals for our 
effect estimates provide evidence that concentrations near 100 µg/L are not associated with markedly 
high relative risks (e.g., much above 3–4). Finally, the fact that the magnitudes of the odds ratios we 
identified are close to those predicted by extrapolations from high doses used by the U.S. 
Environmental Protection Agency and others to set drinking water regulations suggests that these 
extrapolations provide at least somewhat reasonable estimates of low-dose risks [6,8,34]. 
In our study, exposure classification was based on reported residences and the arsenic concentrations 
identified for those residences. Errors in assigning exposure may have occurred as a result of missing 
data, changes in arsenic levels in wells over time, use of proxy respondents, or inaccurate recall of past 
water intake. The impacts of most of these are expected to be small. For example, a previous analysis 
of arsenic concentrations in wells in the study area has shown that they remain stable over many years [25]. 
With regard to proxy interviews, in studies comparing responses of cancer cases and their next of kin, 
spouses were able to identify 70% or more of the residences reported by the cases [35]. Also,  
the percentage of cases and controls with missing or unknown water records was similar. Study 
subjects may have also been exposed to arsenic in food or water outside the study area. However, these 
exposures are unlikely to have caused major misclassification. Inorganic arsenic intake from food is 
generally a fraction of that from drinking water with an arsenic concentration of ≥85 µg/L [36]. 
Although drinking water concentrations ≥85 µg/L do occur in other parts of the U.S., they are 
relatively rare. In an assessment of arsenic levels including the U.S. Environmental Protection 
Agency’s Arsenic Occurrence and Exposure database, Frost et al. identified only one other county 
with arsenic levels similar to those historically seen in Fallon and Hanford (Jim Hogg County, Texas; 
population 5,109; estimated mean county arsenic concentration 77.9 µg/L) [19]. Although participants 
could not perfectly recall how much water they drank in the distant past, it is it is not surprising that 
odds ratios were similar whether or not these data were used, because arsenic concentration was a 
much more important determinant of exposure than water intake. For example, the difference between 
our upper and lower exposure groups in terms of water concentrations was 10–20 fold (<10 versus  
≥85 µg/L), whereas differences in water intake were rarely more than 3-fold. Overall, because 
researchers assessed exposure similarly in all subjects and were blinded to case-control status, 
exposure misclassification was likely non-differential, biasing odds ratios towards the null [37].  
As such, improved exposure assessment likely would have resulted in higher, not lower, odds ratios 
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than those identified. Importantly though, given the relatively low odds ratios identified, and the small 
numbers of subjects in the exposed categories, correcting for this misclassification would most likely 
cause only small changes. For example, correcting for an exposure categorization sensitivity of 70%, 
using the methods described by Rothman and Greenland, would only increase the odds ratio of 1.39 
we identified to 1.40 [38]. 
Odds ratios in this study changed only slightly with adjustment for smoking, known occupational 
lung carcinogens, income, BMI, and education, suggesting that, while these factors differed somewhat 
between cases and controls, they were not strongly related to arsenic exposure and therefore did not 
cause important confounding. Previous studies suggest that smoking and arsenic may act 
synergistically [14–16]. In this study, odds ratios were somewhat higher in analyses confined to 
smokers, but we did not have adequate statistical power to evaluate synergy because of the small 
number of nonsmokers. For example, there were 12 cases and seven controls among smokers, 
compared to 0 cases and 11 controls among nonsmokers with arsenic concentrations ≥85 µg/L at least 
40 years before enrollment, and 0 cases and seven controls among nonsmokers with cumulative 
exposures ≥2,400 µg/L-years lagged 10-years. The low number of non-smokers overall made it 
difficult to evaluate the effects of secondhand smoke. Confounding from other factors like diet, 
occupation, or environmental exposures (e.g., radon) is possible, but there is little evidence that these 
factors were sufficiently related to both lung cancer and arsenic exposure to either cause or mask a 
substantially elevated arsenic-lung cancer odds ratio [39]. 
Although only histologically-confirmed lung cancer cases were requested from the cancer registry and 
hospitals in California and Nevada, data on histological subtypes were not collected. Two recent  
studies [15,40] suggest that ingested arsenic may cause squamous and small cell carcinomas more than 
adenocarcinomas or other subtypes. For example, a study in the northeastern U.S. by Heck et al. reported a 
nearly 3-fold increase in squamous and small cell lung cancer (OR = 2.75; 95% CI = 1.00–7.57) in 
participants with toenail arsenic concentrations ≥0.1137 µg/g, despite no increase in all lung cancer 
types combined [40]. However, given the very low exposures (mostly ≤1 µg/L in drinking water), the 
small sample size (21 cases in the high exposure group), the large effect of adjustments for race, 
education, other lung disease, fish consumption, BMI, and other factors (unadjusted odds ratio of 1.41), 
and the difficulty of interpreting arsenic toenail levels [41], further research is needed to confirm the 
findings of Heck et al. 
5. Conclusions 
Lung cancer odds ratios for arsenic concentrations in drinking water ≥85 µg/L (median = 110 µg/L, 
mean = 173 µg/L, maximum = 1,460 µg/L) more than 40 years before enrollment were greater than 
1.0, but these increases may have been due to chance given the small number of subjects. Our findings 
suggest that concentrations near 100 µg/L are not associated with markedly high relative risks (e.g., 
much above 3–4). The small number of people remaining in exposed areas for the extended latency 
period of arsenic-related cancer shows the difficulties of investigating the health effects of arsenic in 
low-exposure countries with mobile populations like the U.S. and illustrates why nearly all major 
findings on the health effects of arsenic have come from populations with high exposures in Taiwan, 
India, Chile, and Bangladesh [4–15,27,28]. New research on arsenic, including evaluating the impacts 
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of early-life exposures, assessing possible mechanisms, and investigating susceptibility related to 
genetics, epigenetics, diet, co-exposures like smoking, occupation, and other factors, may be best done, 
at least initially, in countries with high exposures. 
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